These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 5253422

  • 1. [Current therapy of malignant blood diseases].
    de Werra P.
    Praxis; 1967 Jun 29; 56(26):901-6. PubMed ID: 5253422
    [No Abstract] [Full Text] [Related]

  • 2. Leukemia and lymphoma.
    White LP.
    Geriatrics; 1970 Dec 29; 25(12):82-6. PubMed ID: 5274229
    [No Abstract] [Full Text] [Related]

  • 3. Adrenal steroids in the treatment of malignant hematologic disease.
    Cline MJ.
    Med Clin North Am; 1973 Sep 29; 57(5):1203-9. PubMed ID: 4205834
    [No Abstract] [Full Text] [Related]

  • 4. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G, Schneider M, Schwarzenberg L, Cattan A, Amiel JL, Schlumberger JR.
    Acta Genet Med Gemellol (Roma); 1968 Jan 29; 17(1):245-54. PubMed ID: 4874537
    [No Abstract] [Full Text] [Related]

  • 5. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J, Stacher A.
    Wien Med Wochenschr; 1966 May 21; 116(21):468-71. PubMed ID: 4863533
    [No Abstract] [Full Text] [Related]

  • 6. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E, Schabel FM, Goldin A.
    Cancer Res; 1974 Jan 21; 34(1):184-93. PubMed ID: 4520419
    [No Abstract] [Full Text] [Related]

  • 7. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
    Cheţa D, Micu D, Cheţa N.
    Med Interne; 1979 Jan 21; 17(4):353-7. PubMed ID: 390678
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experience of use of bruneomycin in leukemia].
    Krasovskiĭ II, Kudinov VG.
    Antibiotiki; 1969 Jan 21; 14(1):77-81. PubMed ID: 5253409
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
    Geib KR, Papazian R.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977 Jan 21; 29(4):343-9. PubMed ID: 22916
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
    Arimori S, Nagao T, Shimizu Y, Watanabe K, Komatsuda M.
    Tokai J Exp Clin Med; 1980 Jan 21; 5(1):63-71. PubMed ID: 6930119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE.
    Lakartidningen; 1969 Jan 29; 66(5):455-60. PubMed ID: 5254602
    [No Abstract] [Full Text] [Related]

  • 19. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
    Bollag W.
    Praxis; 1969 Jun 03; 58(22):703-7. PubMed ID: 5258076
    [No Abstract] [Full Text] [Related]

  • 20. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B, Krakoff I, Burchenal J, Karnofsky D, Golbey R, Dowling M, Oettgen H, Lipton A.
    Cancer; 1970 Feb 03; 25(2):279-305. PubMed ID: 4905154
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.